Report Search Results	As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 23) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 9-Feb-10 New Constructs, LLC N/A ACOR: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10     View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: ACORDA THERAPEUT -- ACOR 1 $4     View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ACOR , AFFY , ANDS , BSTC , OMPI , TELK -- DRUGS 3 $4     View Abstract 5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ACORDA THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20     View Abstract 2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ACOR: the economy's impact on ACOR's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15     View Abstract 31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACORDA THERAPEUTICS INC 5 $25     View Abstract 30-Jan-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Acorda Therapeutics, Inc. 40 $65     View Abstract 26-Jan-10 Wall Street Transcript ,The The Wall St Transcript MANAGEMENT TURNOVER REPORT - Acorda Therapeutics Inc. (ACOR) 7 $50     View Abstract 24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACORDA THERAPEUTICS INC 5 $25     View Abstract 22-Jan-10 Thomson StreetEvents N/A ACOR - Event Transcript of Acorda Therapeutics conference call, Jan. 22, 2010 / 5:30pm ET 15 $75     View Abstract Next 13

Brokerage Reports (Showing 1 to 1 of 1) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 22-Jan-10 Thomson StreetEvents N/A ACOR - Event Transcript of Acorda Therapeutics conference call, Jan. 22, 2010 / 5:30pm ET 15 $75     View Abstract

Independent Reports (Showing 1 to 10 of 22) Release Date  Contributor Author Title Pages Price More Info 9-Feb-10 New Constructs, LLC N/A ACOR: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: ACORDA THERAPEUT -- ACOR 1 $4 View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ACOR , AFFY , ANDS , BSTC , OMPI , TELK -- DRUGS 3 $4 View Abstract 5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ACORDA THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract 2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ACOR: the economy's impact on ACOR's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract 31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACORDA THERAPEUTICS INC 5 $25 View Abstract 30-Jan-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Acorda Therapeutics, Inc. 40 $65 View Abstract 26-Jan-10 Wall Street Transcript ,The The Wall St Transcript MANAGEMENT TURNOVER REPORT - Acorda Therapeutics Inc. (ACOR) 7 $50 View Abstract 24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACORDA THERAPEUTICS INC 5 $25 View Abstract 17-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACORDA THERAPEUTICS INC 5 $25 View Abstract Next 12